TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases (Q2866969): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, it, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Added qualifier: readability score (P590521): 0.000011549083729174788) |
||||||||||||||
| (8 intermediate revisions by 2 users not shown) | |||||||||||||||
| label / pt | label / pt | ||||||||||||||
TERAPI1 .: Protecção dos direitos de Propriedade Intelectual de novos agentes terapêuticos contra doenças amilóides de transtirretina | |||||||||||||||
| label / en | label / en | ||||||||||||||
TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
| Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: Q2988326 (Deleted Item) / rank | |||||||||||||||
| Property / budget | Property / budget | ||||||||||||||
| 48,768.66 Euro
| ||||||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||||||
| 24,384.33 Euro
| ||||||||||||||
| Property / co-financing rate | |||||||||||||||
| |||||||||||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||||||||||
| Property / summary: None (English) / qualifier | |||||||||||||||
readability score: 0.000011549083729174788
| |||||||||||||||
| Property / contained in Local Administrative Unit | |||||||||||||||
| Property / contained in Local Administrative Unit: União das freguesias de Cantanhede e Pocariça / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / priority axis | |||||||||||||||
| Property / priority axis: Research, Development and Innovation (DIIAS) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / co-financing rate | |||||||||||||||
50.0 percent
| |||||||||||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / thematic objective | |||||||||||||||
| Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary | |||||||||||||||
| Property / beneficiary: BSIM THERAPEUTICS, S.A. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / beneficiary name (string) | |||||||||||||||
BSIM THERAPEUTICS, S.A. | |||||||||||||||
| Property / beneficiary name (string): BSIM THERAPEUTICS, S.A. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / date of last update | |||||||||||||||
14 November 2023
| |||||||||||||||
| Property / date of last update: 14 November 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 16:30, 12 March 2024
Project Q2866969 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TERAPI1.: Protection of Intellectual Property rights of new therapeutic agents against amyloid transthyretin diseases |
Project Q2866969 in Portugal |
Statements
24,384.33 Euro
0 references
48,768.66 Euro
0 references
50.0 percent
0 references
20 May 2017
0 references
19 May 2021
0 references
BSIM THERAPEUTICS, S.A.
0 references
40°21'55.76"N, 8°39'29.95"W
0 references
Cantanhede
0 references
14 November 2023
0 references
Identifiers
CENTRO-01-0247-FEDER-028007
0 references